(Q52167619)

English

Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.

scientific article published in June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing. (English)

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

tetrahydrocannabinol

0 references

0 references

Alexandros Makriyannis

3

object named as

A Makriyannis

1 reference

Europe PubMed Central

26 April 2018

author name string

R J Lamb

1

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

T U Järbe

2

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

S Lin

4

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

A Goutopoulos

5

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

European Journal of Pharmacology

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

398

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

2

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

251-258

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Effects of the cannabinoid CB(1) receptor antagonist, SR141716A, after Delta(9)-tetrahydrocannabinol withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Precipitated and spontaneous withdrawal in baboons after chronic dosing with lorazepam and CGS 9896.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Effects of repeated RO 15-1788 administration in benzodiazepine-dependent baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Precipitated Withdrawal by a Benzodiazepine Receptor Antagonist (Ro 15-1788) After 7 Days of Diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Search for endogenous ligands of the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Behavioral effects of benzodiazepine antagonists in chlordiazepoxide tolerant and non-tolerant rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2800%2900318-6

7 January 2021

Identifiers

10.1016/S0014-2999(00)00318-6

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

1 reference

Europe PubMed Central

26 April 2018

http://europepmc.org/abstract/MED/10854837

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52167619&oldid=1373007599"